This Week in Science

In a paper published online in advance in Science this week, researchers at the Washington University School of Medicine report their use of whole-exome sequencing, followed by Sanger re-sequencing, to investigate 31 metastasizing uveal melanoma tumors, in which they identified inactivating somatic mutations in BAP1 on chromosome 3p21.1 in 26 — or 84 percent — of the samples.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.